Literature DB >> 26622697

RNA interference for epidermal growth factor receptor enhances the radiosensitivity of esophageal squamous cell carcinoma cell line Eca109.

Heping Zhang1, Jiancheng Li2, Wenfang Cheng2, D I Liu2, Cheng Chen2, Xiaoying Wang2, Xujing Lu1, Xifa Zhou1.   

Abstract

The present study investigated the effects of small interfering RNAs (siRNAs) specific to the epidermal growth factor receptor (EGFR) gene, on the radiosensitivity of esophageal squamous cell carcinoma cells. EGFR gene siRNAs (EGFR-siRNA) were introduced into esophageal cancer Eca109 cells using Lipofectamine® 2000. The EGFR messenger (m)RNA expression levels, EGFR protein expression and cell growth were assessed using reverse transcription-polymerase chain reaction analysis, western blot analysis and a Cell Counting Kit-8 (CCK-8), respectively. In addition, colony assays were used to determine the inhibitory effects of X-ray radiation on EGFR-silenced cells. EGFR mRNA and protein levels were reduced in the Eca109 cells transfected with EGFR-siRNA. The relative EGFR mRNA expression levels were reduced to 26.74, 9.52 and 4.61% in Eca109 cells transfected with EGFR-siRNA1, 2 and 3, respectively. These mRNA levels were significantly reduced compared with the those of the control group (42.44%; P<0.0001). Transfection with siRNA3 resulted in the greatest reduction in EGFR mRNA expression, with an inhibition rate of 85%. The relative EGFR protein expression levels were reduced to 24.05, 34.91 and 34.14% in Eca109 cells transfected with EGFR-siRNA1, 2 and 3, respectively. These protein levels were significantly reduced compared with those of the control group (78.57%; P<0.0001). Transfection with siRNA1 resulted in the greatest reduction in EGFR protein expression, with an inhibition rate of 72.84%. This reduction in EGFR expression inhibited the proliferation of Eca109 cells, which was identified using the CCK-8 assay. The proliferation inhibition ratio was 28.2%. The cells treated with irradiation in addition to EGFR-siRNA, demonstrated reduced radiobiological parameters (D0, Dq and SF2) compared with those of cells treated with irradiation only, with a sensitization enhancing ratio of 1.5. In conclusion, suppression of EGFR expression may enhance the radiosensitivity of esophageal cancer Eca109 cells and therefore may represent a promising approach for future clinical practice.

Entities:  

Keywords:  cell lines; epidermal growth factor receptor; esophageal neoplasm; radiosensitivity; small interfering RNA

Year:  2015        PMID: 26622697      PMCID: PMC4533743          DOI: 10.3892/ol.2015.3456

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  20 in total

Review 1.  siRNAs: applications in functional genomics and potential as therapeutics.

Authors:  Yair Dorsett; Thomas Tuschl
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

2.  Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06).

Authors:  Thomas Ruhstaller; Miklos Pless; Daniel Dietrich; Helmut Kranzbuehler; Roger von Moos; Peter Moosmann; Michael Montemurro; Paul M Schneider; Daniel Rauch; Oliver Gautschi; Walter Mingrone; Lucas Widmer; Roman Inauen; Peter Brauchli; Viviane Hess
Journal:  J Clin Oncol       Date:  2011-01-04       Impact factor: 44.544

3.  Lentivirus-mediated RNA interference of Ku70 to enhance radiosensitivity of human mammary epithelial cells.

Authors:  Veerle Vandersickel; Monica Mancini; Emanuela Marras; Petra Willems; Jacobus Slabbert; Jan Philippé; Ellen Deschepper; Hubert Thierens; Gianpoalo Perletti; Anne Vral
Journal:  Int J Radiat Biol       Date:  2010-02       Impact factor: 2.694

4.  Impact of neoadjuvant chemotherapy on physical fitness, physical activity, and health-related quality of life of patients with resectable esophageal cancer.

Authors:  Noriatsu Tatematsu; Yasumasa Ezoe; Eiji Tanaka; Manabu Muto; Yoshiharu Sakai; Tadao Tsuboyama
Journal:  Am J Clin Oncol       Date:  2013-02       Impact factor: 2.339

5.  shRNA interference for extracellular signal-regulated kinase 2 can inhibit the growth of esophageal cancer cell line Eca109.

Authors:  Qi Huo; Shu-tao Zheng; Aerziguli Tuersun; Cong-gai Huang; Qing Liu; Xue Zhang; Ilyar Sheyhidin; Xiao-mei Lu
Journal:  J Recept Signal Transduct Res       Date:  2010-06       Impact factor: 2.092

Review 6.  Chemoprevention of esophageal squamous cell carcinoma.

Authors:  Gary D Stoner; Li-Shu Wang; Tong Chen
Journal:  Toxicol Appl Pharmacol       Date:  2007-03-15       Impact factor: 4.219

7.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

8.  EGFR-TK inhibition before radiotherapy reduces tumour volume but does not improve local control: differential response of cancer stem cells and nontumourigenic cells?

Authors:  Mechthild Krause; Jenny Prager; Xuanjing Zhou; Ala Yaromina; Annegret Dörfler; Wolfgang Eicheler; Michael Baumann
Journal:  Radiother Oncol       Date:  2007-05-24       Impact factor: 6.280

9.  Inhibition of epidermal growth factor receptor expression by RNA interference in A549 cells.

Authors:  Min Zhang; Xin Zhang; Chun-Xue Bai; Jie Chen; Min-Q Wei
Journal:  Acta Pharmacol Sin       Date:  2004-01       Impact factor: 6.150

Review 10.  Radiation-induced EGFR-signaling and control of DNA-damage repair.

Authors:  H Peter Rodemann; Klaus Dittmann; Mahmoud Toulany
Journal:  Int J Radiat Biol       Date:  2007 Nov-Dec       Impact factor: 2.694

View more
  2 in total

1.  Celecoxib-erlotinib combination delays growth and inhibits angiogenesis in EGFR-mutated lung cancer.

Authors:  Yi Xiao Li; Jia Le Wang; Meng Gao; Hao Tang; Rong Gui; Yun Feng Fu
Journal:  Am J Cancer Res       Date:  2016-07-01       Impact factor: 6.166

2.  Composites of Nucleic Acids and Boron Clusters (C2B10H12) as Functional Nanoparticles for Downregulation of EGFR Oncogene in Cancer Cells.

Authors:  Damian Kaniowski; Katarzyna Ebenryter-Olbińska; Katarzyna Kulik; Justyna Suwara; Wojciech Cypryk; Agata Jakóbik-Kolon; Zbigniew Leśnikowski; Barbara Nawrot
Journal:  Int J Mol Sci       Date:  2021-05-04       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.